How do businesses develop a strategy that's both low-cost and identified without becoming squeezed in the middle? Describes how Israel's first and greatest multinational, Teva, reached its dominant position that is worldwide in generic pharmaceuticals, an industry that has undergone significant change over the last 20 years.
Analyzes Teva's strategies to defend itself against both low-cost rivals from India and other emerging markets as good as Big Pharma companies, which are adopting increasingly competitive approaches in generics.
Teva Pharmaceutical Industries, Ltd., DVD case solution
PUBLICATION DATE: November 13, 2007 PRODUCT #: 708806-VID-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION
Related Case Solutions & Analyses:
Corporate Reputations: Built In or Bolted On
Note on Corporate Entrepreneurship: Challenge or Opportunity
Hexcel Turnaround–2001 (B)
Nin Jiom: Selling Traditional Chinese Medicine in Modern Hong Kong
Barry Fine
Design Thinking and Innovation at Apple, Chinese Version
Ethics of Offshoring: Novo Nordisk and Clinical Trials in Emerging Economies
Amyris
Social Finance, Inc. (SoFi): The Decision to IPO
Scharffen Berger Chocolate Maker
